{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:26:10Z","timestamp":1768875970845,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12640-016-9639-z","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T09:59:27Z","timestamp":1465811967000},"page":"530-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2\u2032-deoxyguanosine as Plasma Biomarkers of Clinical\/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks"],"prefix":"10.1007","volume":"30","author":[{"given":"S.","family":"Ljubisavljevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Basic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"9639_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","volume":"12","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, Junker A, Tumani H (2006) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Multip Scler 12:143\u2013148","journal-title":"Multip Scler"},{"key":"9639_CR2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cca.2013.06.019","volume":"424","author":"JY Cai","year":"2013","unstructured":"Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, Sun J (2013) Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin Chim Acta 424:182\u2013186","journal-title":"Clin Chim Acta"},{"key":"9639_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang A, Tourtelotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med 346:165\u2013173","journal-title":"New Engl J Med"},{"key":"9639_CR4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","volume":"6","author":"M Coleman","year":"2005","unstructured":"Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6:889\u2013898","journal-title":"Nat Rev Neurosci"},{"key":"9639_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/382107","author":"JM Dale","year":"2012","unstructured":"Dale JM, Garcia ML (2012) Neurofilament phosphorylation during development and disease: which came first, the phosphorylation or the accumulation? J Amino Acids. doi: 10.1155\/2012\/382107","journal-title":"J Amino Acids"},{"key":"9639_CR6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ene.12925","volume":"23","author":"L Bock de","year":"2016","unstructured":"de Bock L, Fraussen J, Villar LM, Alvarez-Cermeno JC, van Wijmeersch B, van Pesch V, Stinissen P, Somers V (2016) Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index. Eur J Neurol 23:722\u2013728","journal-title":"Eur J Neurol"},{"key":"9639_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","volume":"93","author":"R Dutta","year":"2011","unstructured":"Dutta R, Trapp BD (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93:1\u201312","journal-title":"Prog Neurobiol"},{"key":"9639_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/01.WNL.0000041496.58127.E3","volume":"60","author":"MJ Eikelenboom","year":"2003","unstructured":"Eikelenboom MJ, Petzold A, Lazeron RH, Silber E, Sharief M, Thompson EJ, Barkhof F, Giovannoni G, Polman CH, Uitdehaag BM (2003) Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60:219\u2013223","journal-title":"Neurology"},{"key":"9639_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuint.2011.10.011","volume":"60","author":"C Fressinaud","year":"2012","unstructured":"Fressinaud C, Berges R, Eyer J (2012) Axon cytoskeleton proteins specifically modulate oligodendrocyte growth and differentiation in vitro. Neurochem Int 60:78\u201390","journal-title":"Neurochem Int"},{"issue":"4","key":"9639_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225\u2013238","journal-title":"Nat Rev Neurol"},{"key":"9639_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","volume":"69","author":"M Gunnarsson","year":"2011","unstructured":"Gunnarsson M, Malmestr\u00f6m C, Axelsson M, Sundstr\u00f6m P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J (2011) Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 69:83\u201389","journal-title":"Ann Neurol"},{"key":"9639_CR12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider L, Fischer MT, Frischer JM, Bauer J, H\u00f6ftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914\u20131924","journal-title":"Brain"},{"key":"9639_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mad.2013.02.008","volume":"134","author":"KD Jacob","year":"2013","unstructured":"Jacob KD, Hooten NN, Trzeciak AR, Evans MK (2013) Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech Ageing Dev 134:139\u2013157","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"9639_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molbrainres.2005.08.009","volume":"141","author":"C Jung","year":"2005","unstructured":"Jung C, Lee S, Ortiz D, Zhu Q, Julien JP, Shea TB (2005) The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Mol Brain Res 141(2):151\u2013155","journal-title":"Mol Brain Res"},{"key":"9639_CR15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00415-005-0037-3","volume":"253","author":"MW Koch","year":"2006","unstructured":"Koch MW, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253:483\u2013487","journal-title":"J Neurol"},{"key":"9639_CR16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","volume":"76","author":"J Kuhle","year":"2011","unstructured":"Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RL (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76:1206\u20131213","journal-title":"Neurology"},{"key":"9639_CR17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"9639_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210\u2013218","journal-title":"Brain Pathol"},{"issue":"1","key":"9639_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12035-014-9041-x","volume":"53","author":"S Ljubisavljevic","year":"2016","unstructured":"Ljubisavljevic S (2016) Oxidative stress and neurobiology of demyelination. Mol Neurobiol 53(1):744\u2013758","journal-title":"Mol Neurobiol"},{"key":"9639_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey\u2014 National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907\u2013911","journal-title":"Neurology"},{"key":"9639_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awg061","volume":"126","author":"IM Medana","year":"2003","unstructured":"Medana IM, Esiri MM (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515\u2013530","journal-title":"Brain"},{"key":"9639_CR22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","volume":"233","author":"A Petzold","year":"2005","unstructured":"Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233:183\u2013198","journal-title":"J Neurol Sci"},{"key":"9639_CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/jnnp.2004.043315","volume":"76","author":"A Petzold","year":"2005","unstructured":"Petzold A, Eikelenboom MJ, Keir G, Grant D, Lazeron RHC, Polman CH, Uitdehaag BMJ, Thompson EJ, Giovannoni G (2005) Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry 76:206\u2013211","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9639_CR24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ana.22169","volume":"68","author":"A Petzold","year":"2010","unstructured":"Petzold A, Mondria T, Kuhle J, Rocca MA, Cornelissen J, te Boekhorst P, Lowenberg B, Giovannoni G, Filippi M, Kappos L, Hintzen R (2010) Evidence for acute neurotoxicity after chemotherapy. Ann Neurol 68:806\u2013815","journal-title":"Ann Neurol"},{"issue":"2","key":"9639_CR25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"key":"9639_CR26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/01.WNL.0000142043.32578.5D","volume":"63","author":"K Rejdak","year":"2004","unstructured":"Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G (2004) CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63:1439\u20131445","journal-title":"Neurology"},{"key":"9639_CR27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","volume":"45","author":"I Tasset","year":"2012","unstructured":"Tasset I, Aguera E, S\u00e1nchez-L\u00f3pez F, Feij\u00f3o M, Giraldo AI, Cruz AH, Gasc\u00f3n F, T\u00fanez I (2012) Peripheral oxidative stress in relapsing\u2013remitting multiple sclerosis. Clin Biochem 45:440\u2013444","journal-title":"Clin Biochem"},{"issue":"5","key":"9639_CR28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1352458512443092","volume":"18","author":"CE Teunissen","year":"2012","unstructured":"Teunissen CE, Khalil M (2012) Neurofilaments as biomarkers inmultiple sclerosis. Mult Scler J 18(5):552\u2013556","journal-title":"Mult Scler J"},{"issue":"2","key":"9639_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10616-013-9685-9","volume":"67","author":"H Turkez","year":"2015","unstructured":"Turkez H, Togar B, Di Stefano A, Tasp\u0131nar N, Sozio P (2015) Protective effects of cyclosativene on H2O2-induced injury in cultured rat primary cerebral cortex cells. Cytotechnology 67(2):299\u2013309","journal-title":"Cytotechnology"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-016-9639-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:16:03Z","timestamp":1498320963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-016-9639-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["9639"],"URL":"https:\/\/doi.org\/10.1007\/s12640-016-9639-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}